TARDBP and frontotemporal dementia: Due to inherent limitations of immunohistochemistry studies in autopsy tissue discussed in more detail below, additional confirmatory studies based on validated antibodies and antibody-independent spatial proteomic approaches are necessary to determine the scope of RBP mislocalization beyond TDP-43 in sporadic ALS/FTD.